Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TARGIT Collaborative Group is a U.S.-based nonprofit professional and research organization focused on intraoperative radiotherapy, particularly targeted intraoperative radiotherapy used during cancer surgery. It brings together radiation oncologists, breast surgeons, physicists, and related specialists to advance education, patient advocacy, mentorship, and collaborative clinical research. The group is closely associated with dissemination and clinical discussion of TARGIT-IORT for early-stage breast cancer and has hosted recurring annual conferences for clinicians in this field. It does not appear to operate as a traditional drug-development biotech or pharmaceutical company with a proprietary therapeutic pipeline. Instead, it functions as a healthcare-focused collaborative supporting adoption, study, and professional exchange around intraoperative radiation treatment approaches.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TARGIT Collaborative Group.